Table 3.
Polygenic risk score | Cohorts of adult women | Quintile of polygenic score | Model 1 | Model 2 | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Q1 | Q2 | Q3 | Q4 | Q5 | Test | Pmodel 1 | PQ | Pmodel 2 | PQ | ||
PRSTC | Cohort 1 | 0.0481 (0.0466–0.0497) | 0.0496 (0.0482–0.0511) | 0.0503 (0.0487–0.0520) | 0.0501 (0.0486–0.0516) | 0.0497 (0.0482–0.0514) | Linear trend | 0.0534 | 0.1003 | ||
Cohort 2 | 0.0481 (0.0450–0.0515) | 0.0504 (0.0453–0.0561) | 0.0529 (0.0479–0.0584) | 0.0550 (0.0496–0.0610) | 0.0512 (0.0479–0.0547) | Linear trend | 0.1032 | 0.0758 | |||
Meta-analysis | 0.0182 | 0.3547 | 0.0315 | 0.2560 | |||||||
Cohort 1 | 0.0495 (0.0488–0.0503) | 0.0497 (0.0482–0.0514) | Top 20% vs others | 0.6893 | 0.7445 | ||||||
Cohort 2 | 0.0518 (0.0493–0.0544) | 0.0512 (0.0479–0.0547) | Top 20% vs others | 0.8236 | 0.9732 | ||||||
Meta-analysis | 0.7591 | 0.7336 | 0.7667 | 0.8891 | |||||||
PRSTG | Cohort 1 |
0.0499 (0.0485–0.0514) |
0.0498 (0.0481–0.0515) |
0.0491 (0.0475–0.0507) |
0.0494 (0.0481–0.0507) |
0.0498 (0.0480–0.0516) |
Linear trend | 0.7416 | 0.7173 | ||
Cohort 2 |
0.0515 (0.0471–0.0563) |
0.0514 (0.0481–0.0548) |
0.0512 (0.0477–0.0549) |
0.0542 (0.0457–0.0643) |
0.0507 (0.0469–0.0548) |
Linear trend | 0.6197 | 0.9116 | |||
Meta-analysis | 0.6430 | 0.7068 | 0.7048 | 0.9963 | |||||||
Cohort 1 | 0.0495 (0.0488–0.0503) | 0.0498 (0.0480–0.0516) | Top 20% vs others | 0.9536 | 0.9879 | ||||||
Cohort 2 | 0.0518 (0.0495–0.0542) | 0.0507 (0.0469–0.0548) | Top 20% vs others | 0.4509 | 0.9879 | ||||||
Meta-analysis | 0.8786 | 0.4574 | 0.9917 | 0.9849 | |||||||
PRSHDL | Cohort 1 |
0.0512 (0.0497–0.0527) |
0.0490 (0.0475–0.0505) |
0.0496 (0.0479–0.0513) |
0.0483 (0.0469–0.0498) |
0.0498 (0.0482–0.0514) |
Linear trend | 0.3786 | 0.3242 | ||
Cohort 2 |
0.0511 (0.0470–0.0556) |
0.0542 (0.0466–0.0630) |
0.0498 (0.0459–0.0539) |
0.0532 (0.0491–0.0576) |
0.0508 (0.0475–0.0542) |
Linear trend | 0.9307 | 0.8528 | |||
Meta-analysis | 0.4194 | 0.7165 | 0.3205 | 0.8838 | |||||||
Cohort 1 |
0.0512 (0.0497–0.0527) |
0.0492 (0.0484–0.0500) | Bottom 20% vs others | 0.0212 | 0.0160 | ||||||
Cohort 2 |
0.0511 (0.0470–0.0556) |
0.0518 (0.0495–0.0542) | Bottom 20% vs others | 0.4012 | 0.4524 | ||||||
Meta-analysis | 0.0533 | 0.1286 | 0.0405 | 0.1373 | |||||||
PRSLDL | Cohort 1 |
0.0481 (0.0467–0.0495) |
0.0498 (0.0484–0.0513) |
0.0489 (0.0475–0.0503) |
0.0514 (0.0494–0.0536) |
0.0495 (0.0482–0.0509) |
Linear trend | 0.0485 | 0.0954 | ||
Cohort 2 |
0.0509 (0.0452–0.0574) |
0.0516 (0.0458–0.0581) |
0.0533 (0.0485–0.0585) |
0.0545 (0.0504–0.0590) |
0.0490 (0.0465–0.0517) |
Linear trend | 0.9030 | 0.7916 | |||
Meta-analysis | 0.0570 | 0.5840 | 0.0972 | 0.7430 | |||||||
Cohort 1 | 0.0496 (0.0488–0.0504) |
0.0495 (0.0482–0.0509) |
Top 20% vs others | 0.7463 | 0.7438 | ||||||
Cohort 2 | 0.0526 (0.0500–0.0553) |
0.0490 (0.0465–0.0517) |
Top 20% vs others | 0.2775 | 0.3636 | ||||||
Meta-analysis | 0.9340 | 0.2564 | 0.9800 | 0.3328 |
Data are presented as geometric mean (95% CI) stratified by quintile categories of polygenic risk score. Intima-media thickness was natural log (ln) transformed. Pmodel 1 and Pmodel 2 values were obtained from linear regression with the adjustment for covariates included in models 1 and 2, respectively. Model 1: principal components and age. Model 2: principal components, age, body mass index, and systolic blood pressure. Results from individual cohorts were meta-analyzed using a fixed effects model. PQ refers to the p value of Cochran’s Q-statistics in heterogeneity test. Associations between PRSs and carotid intima-media thickness were examined in two different ways: (1) we examined a linear trend across the quintile categories. (2) We tested a hypothesis that a high PRS for TC, TG, and LDL-C (a low PRS for HDL-C) was associated with intima media thickness by comparing the top (bottom) 20% with the remaining 80% of the PRS distribution